Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
acetaminophen + gamma-aminobutyric acid + codeine
- Development stage
- Approved
- Lead developer
- Physician Therapeutics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Acetaminophen + gamma-aminobutyric acid + codeine** is an oral combination analgesic product corresponding to Physician Therapeutics' convenience-packaged **Theracodeine-300**, which pairs acetaminophen 300 mg and codeine 30 mg with the medical food Theramine, an amino-acid formulation containing gamma-aminobutyric acid. The product is intended for the treatment of mild to moderately severe pain. Mechanistically, acetaminophen provides non-opioid analgesic and antipyretic activity through primarily central analgesic pathways, codeine acts as an opioid analgesic via mu-opioid receptor agonism after metabolic activation, and gamma-aminobutyric acid is included as part of the Theramine component for dietary management of pain and inflammation. This is best characterized as an orally administered combination product that co-packages a pharmaceutical analgesic with a medical food component.
- Other names
- acetaminophen + gamma-aminobutyric acid + codeineacetaminophen and codeine phosphate tablets + Theramine
02
Targets
MOR (Mu opioid receptor)
Beyond the preview
Go deeper on acetaminophen + gamma-aminobutyric acid + codeine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on acetaminophen + gamma-aminobutyric acid + codeine.